Go to Top

Tag Archives

Tag Archives: PPHM

Peregrine Pharmaceuticals (PPHM): Update on the Internal Review of Its Phase II Lung Cancer Trial

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials focused on the treatment and diagnosis of cancer. Company is pursuing multiple clinical programs in cancer with our lead product candidate bavituximab and novel brain cancer agent Cotara®. Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned …Read More